[Form 4] IREN Limited Insider Trading Activity

Rhea-AI Filing Summary

Daniel John Roberts, a director and Co-Chief Executive Officer of IREN Ltd (IREN), reported a sale of ordinary shares on 09/11/2025. The Form 4 shows a disposition of 1,000,000 ordinary shares at a price of $33.131 per share. After the reported transaction, the filing states the reporting person beneficially owns 13,989,696 shares indirectly through the Awassi Capital Trust #2, over which he has control of the trustee. The filing includes a disclaimer that he disclaims beneficial ownership except to the extent of his pecuniary interest.

Insights

Securities Analyst

TL;DR: Insider sale of 1,000,000 IREN shares at $33.131 reduces indirect holdings to 13,989,696 via a controlled trust.

This Form 4 documents a straightforward Section 16 disposition by an executive who is both a director and Co-CEO. The sale size and price are explicit; the shares remain reported as indirectly owned through Awassi Capital Trust #2, with a disclaimer limiting claimed beneficial ownership to pecuniary interest. For investors, this is a clear insider liquidity event without additional contextual details such as intended use of proceeds or a 10b5-1 plan stated on the form.

Corporate Governance Expert

TL;DR: Transaction is a disclosed, controlled-trust sale by a senior executive; documentation and signature are present.

The filing includes the required signature by an attorney-in-fact and an explanatory footnote about the trust arrangement. The report identifies the reporting persons roles and confirms indirect ownership through a trust for which he controls the trustee. The form does not indicate amendments or multiple filers. From a governance perspective, disclosure appears procedurally complete based on the provided content.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roberts Daniel John

(Last) (First) (Middle)

C/O IREN LIMITED

LEVEL 6, 55 MARKET STREET

(Street)

SYDNEY C3 2000

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IREN Ltd [ IREN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Co-Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	09/11/2025		S		1,000,000	D	$33.131	13,989,696	I	By Awassi Capital Trust #2(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents ordinary shares of IREN Limited and restricted stock units held through the Awassi Capital Trust #2, of which the Reporting Person has control over the trustee. The Reporting Person disclaims beneficial ownership of the ordinary shares and restricted stock units, except to the extent of his pecuniary interest therein.

	/s/ Cesilia Kim, attorney-in-fact for Daniel J. Roberts	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.